Request for Consideration: Streamlining Medical Device Registration process/ Regulatory Challenges

[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”4.16″ global_colors_info=”{}”][et_pb_row admin_label=”row” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text admin_label=”Text” _builder_version=”4.17.4″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]

AMCHAM’s Medical Device Committee made a representation on streamlining medical device registration process/regulatory challenges to Major General Mohammad Yousuf, Director General, Directorate General of Drug Administration, Ministry of Health & Welfare, Bangladesh on August 1st, 2022. The recommendation highlighted DGDA capacity challenges, handling of administrative changes like manufacturer name change and M.R P. (Maximum Retail Price) to help industry stakeholders to obtain faster approvals thereby enabling Bangladesh patients’ access to affordable, new, innovative and novel medical technology devices.

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]